Kerala High Court Affirms Centre's Power to Make Patented Life-Saving Drugs

The Kerala High Court has ruled that the Union government holds the authority under the Patents Act to manufacture patented life-saving medicines and offer them to patients at reduced prices. The judgment addresses access to essential drugs for those unable to meet the cost of patented treatments.

The case originated in a petition filed by a cancer patient who required a patented medicine. She did not survive long enough to hear the court's decision, which was delivered four years after her death.

The court's finding turns on the powers available to the Centre under the Patents Act, which governs the grant and use of patents in the country. Its interpretation affirms that the government can step in to produce such medicines itself and sell them at rates below those set by patent holders, extending relief to patients who would otherwise be priced out.

The ruling is significant for the broader debate over the balance between patent protections held by pharmaceutical companies and the affordability of critical treatments. It also underscores the role of the judiciary in clarifying the scope of statutory powers available to the executive in matters of public health.